These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 5250309
1. Steroids and moods: correlations in schizophrenics and subjects treated with lysergic acid diethylamide (LSD), mescaline, tetrahydrocannabinol, and synhexyl. Hollister LE. J Clin Pharmacol J New Drugs; 1969; 9(1):24-9. PubMed ID: 5250309 [No Abstract] [Full Text] [Related]
2. [Mescaline, lysergic acid diethylamide (LSD 25) & menstruation]. SALERNO EV, TALLAFERRO A. Sem Med; 1957 Jan 10; 110(2):47-8; passim. PubMed ID: 13421863 [No Abstract] [Full Text] [Related]
3. Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state. Denber HC. Dis Nerv Syst; 1969 Feb 10; 30(2):Suppl:23-7. PubMed ID: 5775311 [No Abstract] [Full Text] [Related]
4. The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach). Itil TM, Keskiner S, Holden JM. Dis Nerv Syst; 1969 Feb 10; 30(2):Suppl:93-103. PubMed ID: 4388281 [No Abstract] [Full Text] [Related]
5. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25). Teresa M, Silva A, Carlini EA, Claussen U, Korte F. Psychopharmacologia; 1968 Feb 10; 13(4):332-40. PubMed ID: 5722169 [No Abstract] [Full Text] [Related]
6. The experimental use of psychedelic (LSD) psychotherapy. Pahnke WN, Kurland AA, Unger S, Savage C, Grof S. Int Z Klin Pharmakol Ther Toxikol; 1971 Jun 10; 4(4):446-54. PubMed ID: 5566727 [No Abstract] [Full Text] [Related]
8. Remarks on LSD and mescaline. HOCH PH. J Nerv Ment Dis; 1957 Jun 10; 125(3):442-4. PubMed ID: 13481753 [No Abstract] [Full Text] [Related]
9. [Excretion of 17-ketosteroids and 17-hydroxysteroids during the course of treatment of schizophrenia with chlorpromazine]. Wasik A, Cymbala J. Neurol Neurochir Psychiatr Pol; 1966 Feb 10; 16(2):173-7. PubMed ID: 5913353 [No Abstract] [Full Text] [Related]
11. [Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders]. LARICCHIA R, SANGUINETI I, ZAPPAROLI GC. Riv Sper Freniatr Med Leg Alien Ment; 1956 Oct 01; 80(4):887-918. PubMed ID: 13390719 [No Abstract] [Full Text] [Related]
12. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD). KOELLE GB. N Engl J Med; 1958 Jan 02; 258(1):25-32. PubMed ID: 13493730 [No Abstract] [Full Text] [Related]
17. [Prospective psychiatry; the time factor]. JOST F, PEMSL H. Munch Med Wochenschr; 1957 Jun 14; 99(24):889-91. PubMed ID: 13451569 [No Abstract] [Full Text] [Related]
18. Effects of various drugs on clinical psychopathology. PENNES HH. Proc Annu Meet Am Psychopathol Assoc; 1957 Jun 14; ():236-45. PubMed ID: 13441673 [No Abstract] [Full Text] [Related]
19. Use of drugs in psychodynamic investigations. CATTELL JP. Proc Annu Meet Am Psychopathol Assoc; 1957 Jun 14; ():218-35. PubMed ID: 13441672 [No Abstract] [Full Text] [Related]
20. A new adjunct to the treatment of alcoholism: the hallucinogenic drugs. SMITH CM. Q J Stud Alcohol; 1958 Sep 14; 19(3):406-17. PubMed ID: 13579169 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]